Director/PDMR Shareholding
On October 20, 2025, Oxford Biomedica PLC announced that Kyriacos Mitrophanous, Chief Innovation Officer, exercised 26,210 LTIP options at a nil exercise price. Simultaneously, Mitrophanous disposed of 26,210 ordinary shares at an average price of £5.758376 per share, resulting in a total aggregated sale value of £150,927.03. The transactions took place on the London Stock Exchange, Main Market (XLON).
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 20 October 2025: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that Kyriacos Mitrophanous, Chief Innovation Officer of the Company, exercised 26,210 LTIP options at nil exercise price on 20 October 2025 and disposed of 26,210 shares at an average price of £5.758376 per share on 20 October 2025.
| a) | Name | Kyriacos Mitrophanous | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Person Discharging Managerial Responsibility | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Full name of the entity | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 2025-10-20 | ||||
| b) | Description of the financial instrument | Options over Ordinary Shares of 50 pence each | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of the transaction | Exercise of LTIP Options at nil exercise price | ||||
| e) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 26,210 £0.00 £0.00 | ||||
| a) | Name | Kyriacos Mitrophanous | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Person Discharging Managerial Responsibility | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Name | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 2025-10-20 | ||||
| b ) | Description of the financial instrument | Ordinary Shares of 50 pence each | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of transaction | Sale of shares | ||||
| e) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 26,210 £5.758376 £150,927.03 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.